CTSE and pancreatic ductal adenocarcinoma: Specifically, cathepsin E has been found to have high expression and activity in pancreatic ductal adenocarcinoma (PDAC) (46), while cathepsin B has been shown to play a significant role in the autonomous growth of PDAC, potentially promoting tumor cell proliferation through the regulation of cathepsin L (16).